IL-6 gene polymorphisms and CAD risk: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2589-2598

  Yang, Yuan ^a   Zhang, Fan ^a   Skrip, Laura ^b   Lei, Han ^a   Wang, Yang ^a   Hu, Dayi ^a   Ding, Rongjing ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b YALE UNIVERSITY   (United States)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

174 G C; 572 G C; Coronary artery disease; IL 6 gene; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ACUTE CORONARY SYNDROME; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DOMINANT GENE; ETHNICITY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HEART INFARCTION; HUMAN; PATHOGENESIS; RECESSIVE GENE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84878417334     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2345-x     Document Type: Article

References (53)

1. Writing group members, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S et al (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121(7):46-215
2. Lloyd-Jones DM, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease. Lancet 353:89-92
3. Mehta JL, Saldeen TG, Rand K (1998) Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31(6):1217-1225
4. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Eng J Med 352:1685-1695
5. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
6. Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T (1990) Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int 20:445-453
7. Ikeda U, Ito L, shimad K (2001) Interleukin-6 and acute coronary syndrome. Clin Cardiol 24:1574-1583
8. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209-214
9. Woods A, Brull DJ, Humphries SE et al (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin 6. Eur Heart J 21(19):1574-1583
10. Moher D, Liberati A, Tetzlaff J (2009) PRISMA group. preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
11. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Darrell L et al (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156:300-310
12. Overton, Randall C (1998) A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests of moderator variable effects. Psychol Methods 3(3):354-379
13. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24(9):1291-1306
14. Camargo MC, Mera R, Correa P, Peek RM Jr, Fontham ET, Goodman KJ et al (2006) Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(9):1674-1687
15. Arj-Ong S, Thakkinstian A, McEvoy M, Attia J (2010) A systematic review and meta-analysis of tumor necrosis factor α-308 polymorphism and Kawasaki disease. Pediatr Int 52(4):527-532
16. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
17. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
18. Vakili H, Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS, Azargashb E (2011) Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 22(5):299-305
19. Coker A, Arman A, Soylu O, Tezel T, Yildirim A (2011) Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet 38(3):201-208
20. Bennermo M, Nordin M, Lundman P, Boqvist S, Held C, Samnegård A et al (2011) Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J Interferon Cytokine Res 31(2):259-264
21. Fragoso JM, Delgadillo H, Juárez-Cedillo T, Rodríguez- Pérez JM, Vallejo M, Pérez-Méndez O et al (2010) The interleukin 6-572 G > C (rs1800796) polymorphism is associated with the risk of developing acute coronary syndrome. Genet Test Mol Biomarkers 14(6):759-763
22. Ghazouani L, Ben Hadj Khalifa S, Abboud N, Ben Hamda K, Ben Khalfallah A, Brahim N et al (2010) TNF-alpha -308G > A and IL-6 -174G > C polymorphisms in Tunisian patients with coronary artery disease. Clin Biochem 43(13-14):1085-1089
23. Rios DL, Cerqueira CC, Bonfim-Silva R, Araújo LJ, Pereira JF, Gadelha SR et al (2010) Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians. Cytokine 50(3):292-296
24. Jia X, Tian Y, Wang Y, Deng X, Dong Z, Scafa N et al (2010) Association between the interleukin-6 gene -572G/C and -597G/A polymorphisms and coronary heart disease in the Han Chinese. Med Sci Monit 16(3):CR103-CR108
25. Sarecka-Hujar B, Zak I, Krauze J (2008) Carrier-state of two or three polymorphic variants of MTHFR, IL-6 and ICAM1 genes increases the risk of coronary artery disease. Kardiol Pol 66(12):1269-1277
26. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27(1):88-94
27. Fu HX, Li GS, Li Y, Xu JL, Zhang JY (2006) Interleukin-6 -597G/A and -572C/G polymorphisms and risk of coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 34(6):519-522 [Chinese]
28. Wei YS, Lan Y, Liu YG, Tang RG, Lan JS (2006) Relationship between interleukin-6 gene polymorphism and coronary heart disease and its effect on plasma lipid levels. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18(4):233-236 [Chinese]
29. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Caldarera CM, Nanni S et al (2005) Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32(6):349-353
30. Rosner SA, Ridker PM, Zee RY, Cook NR (2005) Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the physician's health study. Hum Genet 118(2):287-294
31. Kelberman D, Hawe E, Luong LA, Mohamed-Ali V, Lundman P, Tornvall P et al (2004) Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 92(5):1122-1128
32. Lieb W, Pavlik R, Erdmann J, Mayer B, Holmer SR, Fischer M et al (2004) No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 97(2):205-212
33. Licastro F, Chiappelli M, Caldarera CM, Tampieri C, Nanni S, Gallina M et al (2004) The concomitant presence of polymorphic alleles of interleukin-1 beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 125(8):575-579
34. Nauck M, Winkelmann BR, Hoffmann MM, Böhm BO, Wieland H, März W (2002) The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med Berl 80(8):507-513
35. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22(24):2243-2252
36. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D et al (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med Berl 79(5-6):300-305
37. Fan WH, Liu DL, Xiao LM, Xie CJ, Sun SY, Zhang JC (2011) Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population? Oral Dis 17(3):270-276
38. Carty CL, Heagerty P, Heckbert SR, Jarvik GP, Lange LA, Cushman M et al (2010) Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet 74(1):1-10
39. Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B et al (2009) Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant 24(9):2847-2851
40. Berg KK, Madsen HO, Garred P, Wiseth R, Gunnes S, Videm V (2009) The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand J Immunol 69(1):36-42
41. Sarecka B, Zak I, Krauze J (2008) Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin Biochem 41(7-8):467-473
42. Bis JC, Heckbert SR, Smith NL et al (2000) Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198(1):166-173
43. Mälarstig A, Wallentin L, Siegbahn A (2007) Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res 119(4):467-473
44. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A et al (2006) Interleukin 6-174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26(1):212-217
45. Ortlepp JR, Krantz C, Kimmel M, von Korff A, Vesper K, Schmitz F et al (2005) Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol 105(1):90-95
46. Antonicelli R, Olivieri F, Bonafè M, Cavallone L, Spazzafumo L, Marchegiani F et al (2005) The interleukin-6 -174 G > C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103(3):266-271
47. Morange PE, Saut N, Alessi MC, Frere C, Hawe E, Yudkin JS et al (2005) Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 179(2):317-323
48. Latkovskis G, Licis N, Kalnins U (2004) C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 31(5):207-213
49. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M et al (2004) Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 25(11):970-977
50. Bennermo M, Held C, Green F, Strandberg LE, Ericsson CG, Hansson LO et al (2004) Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis 174(1):157-163
51. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A et al (2001) Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21:1458-1463
52. Jenny NS, Tracy RP, Ogg MS, le Luong A, Kuller LH, Arnold AM et al (2002) In the elderly, interleukin-6 plasma levels and the -174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22(12):2066-2071
53. Niu W, Liu Y, Qi Y, Wu Z, Zhu D, Jin W (2012) Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing Mendelian randomization approach. Int J Cardiol 157(2):243-252